Efficacy analyses per region showed hazard ratios similar to those of the whole intention-to-treat ( ITT ) population for progression-free survival ( ITT : @ ; Asia : @ ; other regions : @ ) and overall survival ( ITT : @ ; Asia : @ ; other regions : @ ) .